Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using phage lytic enzymes to control pathogenic bacteria.

Vincent A Fischetti1

  • 1Rockefeller University, New York, NY 10021, USA. vaf@mail.rockefeller.edu

BMC Oral Health
|August 29, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Second-generation lysocins as therapeutics for treating <i>Pseudomonas aeruginosa</i> infections.

Antimicrobial agents and chemotherapy·2025
Same author

Engineered Lysin-Derived Peptide as a Potent Antimicrobial for Acne Vulgaris.

Antibiotics (Basel, Switzerland)·2025
Same author

Novel Anti-Microbial/Anti-Inflammatory Combination Improves Clinical Outcome of Bacillus cereus Endophthalmitis.

Investigative ophthalmology & visual science·2025
Same author

Gram-negative anaerobes elicit a robust keratinocytes immune response with potential insights into HS pathogenesis.

Experimental dermatology·2024
Same author

Quantifying how much host, pathogen, and other factors affect human protective adaptive immune responses.

Frontiers in immunology·2024
Same author

<i>Clostridium perfringens</i> Epsilon Toxin Binds to and Kills Primary Human Lymphocytes.

Toxins·2023

Phage lytic enzymes effectively eliminate disease bacteria like Streptococcus pneumoniae and Bacillus anthracis. These novel enzymes show promise in preventing and treating serious infections in animal models.

Area of Science:

  • Microbiology
  • Biotechnology
  • Infectious Diseases

Background:

  • Bacterial infections pose significant threats, particularly in healthcare settings.
  • Traditional antimicrobial strategies face challenges like resistance.
  • Phage lytic enzymes offer a targeted approach to bacterial destruction.

Purpose of the Study:

  • To develop and evaluate phage lytic enzymes for combating specific bacterial pathogens.
  • To assess the efficacy of these enzymes in preventing and treating infections on mucous membranes and in the bloodstream.

Main Methods:

  • Development of specific phage lytic enzymes targeting Streptococcus pneumoniae, Streptococcus pyogenes, and Bacillus anthracis.
  • Administration of enzymes via nasal, oral, or intravenous routes in animal models.

Related Experiment Videos

  • Evaluation of decolonization and survival rates post-treatment.

    • Main Results:

    • Enzymes targeting S. pneumoniae and S. pyogenes demonstrated efficacy for nasal and oral applications.
    • A B. anthracis-specific enzyme effectively targeted vegetative forms in the blood.
    • Over 80% of treated mice were decolonized or survived single-dose enzyme treatment.

    Conclusions:

    • Phage lytic enzymes represent a promising strategy for controlling specific bacterial infections.
    • Targeted enzyme therapy can prevent serious infections in vulnerable populations and treat existing bacteremia.
    • Further research may lead to novel antimicrobial therapies with high specificity and efficacy.